Fortrea

Update in progress

FTRE (NasdaqGS)

Company RatingNeutral
SectorHealthcare
IndustryBiotechnology

Fortrea Holdings Inc. is a contract research organization delivering biopharmaceutical product and medical device development solutions to customers worldwide. It provides clinical pharmacology, bioanalysis, pharmacokinetics, modeling and simulation, study design and monitoring, data management, biostatistics, pharmacovigilance, medical writing, site start-up, patient recruitment, and end-to-end clinical development (Phases I–IV) plus real-world evidence. It also offers regulatory, market access, health economics, and outcomes research consulting and RWE services. Incorporated 2023, headquartered in Durham, North Carolina.

Company score

Sentiment: -0.02; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: -0.02; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.15; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -0.04; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: -0.03; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive